Quest Diagnostics to acquire Solstas Lab Partners for $570M Quest Diagnostics announced that it has entered into a definitive agreement under which Quest will acquire Solstas Lab Partners Group and its subsidiaries for a total transaction value of approximately $570M. Quest Diagnostics expects the transaction to add approximately 5% in annualized revenues, about 1% of which will be from professional lab services, and be modestly accretive to adjusted earnings per share in 2014. The company expects to complete the acquisition in the first half of 2014, subject to the satisfaction of customary closing conditions.
Quest to acquire MemorialCare's laboratory outreach service business Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.